Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $247,731 - $320,702
-6,184 Closed
0 $0
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $346,603 - $453,579
-9,509 Reduced 60.59%
6,184 $294,000
Q1 2024

May 13, 2024

SELL
$42.03 - $53.55 $1.94 Million - $2.47 Million
-46,046 Reduced 74.58%
15,693 $680,000
Q4 2023

Oct 21, 2024

SELL
$43.39 - $51.63 $2.5 Million - $2.98 Million
-57,661 Reduced 48.29%
61,739 $3.12 Million
Q4 2023

Feb 07, 2024

SELL
$43.39 - $51.63 $2.5 Million - $2.98 Million
-57,661 Reduced 48.29%
61,739 $3.12 Million
Q3 2023

Oct 21, 2024

BUY
$38.5 - $47.13 $524,832 - $642,476
13,632 Added 12.89%
119,400 $5.42 Million
Q3 2023

Nov 07, 2023

BUY
$38.5 - $47.13 $524,832 - $642,476
13,632 Added 12.89%
119,400 $5.42 Million
Q2 2023

Oct 21, 2024

BUY
$34.73 - $43.33 $3.46 Million - $4.31 Million
99,584 Added 1610.35%
105,768 $4.34 Million
Q2 2023

Aug 07, 2023

BUY
$34.73 - $43.33 $3.67 Million - $4.58 Million
105,768 New
105,768 $4.34 Million
Q3 2022

Nov 07, 2022

SELL
$36.54 - $48.66 $1.03 Million - $1.37 Million
-28,255 Reduced 24.6%
86,602 $3.83 Million
Q2 2022

Aug 09, 2022

BUY
$31.71 - $43.0 $159,501 - $216,290
5,030 Added 4.58%
114,857 $4.25 Million
Q1 2022

May 12, 2022

SELL
$29.88 - $37.04 $318,909 - $395,327
-10,673 Reduced 8.86%
109,827 $4.07 Million
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $3.09 Million - $4.23 Million
120,500 New
120,500 $3.67 Million
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $2.09 Million - $2.53 Million
-62,400 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $2.16 Million - $2.95 Million
62,400 New
62,400 $2.49 Million
Q4 2020

Feb 12, 2021

SELL
$45.3 - $60.27 $286,930 - $381,750
-6,334 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $300,548 - $398,725
6,334 New
6,334 $301,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.